InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024

By InvestorPlace Earnings

Applied DNA Sciences just reported results for the third quarter of 2024.

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

AXDX Stock Earnings: Accelerate Diagnostics Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

AXDX stock results show that Accelerate Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024

By InvestorPlace Earnings

APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the second quarter of 2024.

Load More